HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152,658 | +2.8% | 180,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $148,500 | -2.2% | 180,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $151,884 | -13.0% | 180,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $174,488 | +14.0% | 180,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $153,000 | -3.8% | 180,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $159,000 | – | 180,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 89,152 | $76,268,000 | 5.41% |
CAMDEN ASSET MANAGEMENT L P /CA | 64,461,000 | $54,550,000 | 1.83% |
Penn Mutual Asset Management | 1,305,000 | $1,105,000 | 1.45% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 79,311,000 | $67,117,000 | 1.23% |
ZAZOVE ASSOCIATES LLC | 9,978,000 | $8,481,000 | 0.77% |
ADVENT CAPITAL MANAGEMENT /DE/ | 29,500,000 | $25,112,000 | 0.46% |
SHENKMAN CAPITAL MANAGEMENT INC | 8,279,000 | $7,014,000 | 0.39% |
SSI INVESTMENT MANAGEMENT LLC | 5,833,000 | $4,936,000 | 0.33% |
Lombard Odier Asset Management (Europe) Ltd | 6,266,000 | $5,334,000 | 0.28% |
MACKAY SHIELDS LLC | 7,716,000 | $6,568,000 | 0.17% |